Table 1 Retention in HIV care status by demographic and clinical characteristics of the adolescents (10–19 years) on ART in Windhoek District, Khomas Region, Namibia 2019–2021 (N = 695)
| Â | Â | Retained in care (Months) | ||||
|---|---|---|---|---|---|---|
Characteristic | Total | 6 | 12 | 18 | 24 | 36 |
Overall | 695 (%) | 679 (97.7) | 654 (94.1) | 642 (92.4) | 627 (90.2) | 588 (84.6) |
Sex | Â | Â | Â | Â | Â | Â |
Female | 394 (56.7) | 380(96.4) | 361(91.6) | 353(89.6) | 346 (87.8) | 325 (82.5) |
Male | 301 (43.3) | 299 (99.3) | 293 (97.3) | 289 (96.0) | 281 (93.4) | 263 (87.4) |
Age group (years) | Â | Â | Â | Â | Â | Â |
10–14 | 264 (38.0) | 262 (99.2) | 261 (98.9) | 257 (97.3) | 254(96.2) | 240 (90.9) |
15–19 | 431 (62.0) | 417 (96.8) | 393 (91.2) | 385 (89.3) | 373 (86.5) | 348 (80.7) |
Age at ART initiation (years) | Â | Â | Â | Â | Â | Â |
0–9 | 511 (73.5) | 506 (99.0) | 501 (98.0) | 493(96.5) | 487(95.3) | 457 (89.4) |
10–14 | 96 (13.8) | 92 (95.8) | 89 (92.7) | 89 (92.7) | 83 (86.5) | 78 (81.3) |
15–19 | 88 (12.7) | 81(92.0) | 64 (72.7) | 60(68.2) | 57 (64.8) | 53 (60.2) |
Duration on ART (months) | Â | Â | Â | Â | Â | Â |
0–6 | 80 (11.5) | 73 (91.3) | 56 (70.0) | 52 (65.0) | 51 (63.7) | 47 (58.8) |
7–12 | 4 (0.6) | 3 (75.0) | 3 (75.0) | 3 (75.0) | 2 (50.0) | 2 (50.0) |
13–18 | 10 (1.4) | 10 (100.0) | 10 (100.0) | 10(100.0) | 10 (100.0) | 10(100.0) |
19–24 | 10 (1.4) | 10 (100.0) | 9 (90.0) | 9(90.0) | 8 (80.0) | 8 (80.0) |
> 24 | 591 (85.0) | 583 (98.6) | 576 (97.5) | 568 (96.1) | 556 (94.1) | 521 (88.2) |
ART regimen at initiation | Â | Â | Â | Â | Â | Â |
NNRTI based | 636 (91.5) | 620(97.5) | 600 (94.3) | 590 (92.8) | 575(90.4) | 540 (84.9) |
PI based | 48 (6.9) | 48(100.0) | 45(93.8) | 45(93.8) | 45(93.8) | 41 (85.4) |
DTG based | 11 (1.6) | 11 (100.0) | 9(81.8) | 7(63.6) | 7(63.6) | 7 (63.6) |
Current ART regimen | Â | Â | Â | Â | Â | Â |
First line | 647 (93.1) | 634(98.0) | 612(94.6) | 603(93.2) | 590(91.2) | 554 (85.6) |
Second line | 46 (6.6) | 43(93.5) | 40(87.0) | 37 (80.4) | 35 (76.1) | 33 (71.7) |
Third line | 2 (0.3) | 2 (100.0) | 2(100.0) | 2(100.0) | 2(100.0) | 1 (50.0) |
HIV Disclosure status | Â | Â | Â | Â | Â | Â |
Disclosed | 667 (99.0) | 652(97.8) | 627(94.0) | 618(92.7) | 605 (90.7) | 567 (85.0) |
Not disclosed | 7 (1.0) | 7 (100.0) | 7(100.0) | 4(57.1) | 3(42.9) | 3 (42.9) |
Missing | 21 (3.0) | Â | Â | Â | Â | Â |
TB Screen results | Â | Â | Â | Â | Â | Â |
Incomplete | 23 (3.3) | 20(87.0) | 19 (82.6) | 19(82.6) | 16(69.6) | 14 (60.9) |
Negative | 654 (94.1) | 642(98.2) | 621(95.0) | 609(93.1) | 597(91.3) | 561 (85.8) |
Positive | 18 (2.6) | 17(94.4) | 14(77.8) | 14(77.8) | 14(77.8) | 13 (72.2) |
WHO clinical stage at ART initiation | Â | Â | Â | Â | Â | Â |
1 | 378 (67.3) | 367(97.1) | 353(93.4) | 345(91.3) | 334(88.4) | 315 (83.3) |
2 | 100 (17.8) | 98(98.0) | 92(92.0) | 90(90.0) | 87(87.0) | 80 (80.0) |
3 | 65 (11.6) | 62(95.4) | 59(90.8) | 58(89.2) | 57(87.7) | 52 (80.0) |
4 | 19 (3.4) | 19(100.0) | 19(100.0) | 19(100.0) | 19(100.0) | 16 (84.2) |
Missing | 133 (19.1) | Â | Â | Â | Â | Â |
Facility level | Â | Â | Â | Â | Â | Â |
Health centre | 175 (25.2) | 171(97.7) | 163(93.1) | 160(91.4) | 155(88.6) | 146 (83.4) |
Hospital | 343 (49.4) | 341(99.4) | 341(99.4) | 336(98.0) | 332(96.8) | 313 (91.3) |
PHC clinic | 177 (25.5) | 167(94.4) | 150(84.7) | 146(82.5) | 140(79.1) | 129 (72.9) |
Viral load suppression (copies/ml) | Â | Â | Â | Â | Â | Â |
Fully suppressed (< 40) | 506 (73.0) | 495 (97.8) | 474 (93.7) | 464 (91.7) | 453 (89.5) | 426 (84.2) |
Suppressed (40-1000) | 109 (15.7) | 109 (100) | 107 (98.2) | 106 (97.2) | 104 (95.4) | 95 (87.2) |
Not suppressed (> 1000) | 78 (11.3) | 73 (93.6) | 71 (91.0) | 70 (89.7) | 69 (88.5) | 66 (84.6) |
Missing | 2 (0.3) | Â | Â | Â | Â | Â |